Clinical Trial Update: External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients [NA]

View source ↗

Summary

The trial investigates external drainage of thoracic duct lymph to reduce inflammatory cytokines in septic shock patients. Recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Snippet

Sponsor: University of Pennsylvania | Conditions: Sepsis, Septic Shock | NA | Status: RECRUITING